Back to Search
Start Over
Supplementary Methods, Supplementary Figure Legends, Supplementary Table from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Methods, Supplementary Figure Legends, Supplementary Table
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....0494cbfb70206985634a6c110a3bed99